TXG
NASDAQStock10x Genomics, Inc.
$19.00-1.44 (-7.04%)
52-Week Range
$7.14
$23.19
Key Stats
Market Cap
2.4B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.21
Volume
1.6M
Avg Volume
2.3M
Performance
1M
-1.10%
3M
+20.18%
6M
+41.87%
YTD
+13.96%
1Y
+91.70%
3Y
-61.08%
5Y
-88.83%
Price Chart
ETF Exposure
TXG is held by 91 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| JKJ | iShares Morningstar Small-Cap ETF | 0.04% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.04% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.04% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.03% |
| VHT | Vanguard Health Care ETF | 0.03% |
| TLTD | FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund | 0.03% |
| VB | Vanguard Small-Cap ETF | 0.03% |
| VXF | Vanguard Extended Market ETF | 0.03% |
| DXUV | Dimensional - US Vector Equity ETF | 0.03% |
| SMMD | iShares Russell 2500 ETF | 0.02% |
| DFSU | Dimensional - US Sustainability Core 1 ETF | 0.01% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.01% |
| HDG | ProShares - Hedge Replication ETF | 0.01% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.01% |
| MFDX | PIMCO RAFI Dynamic Multi-Factor International Equity ETF | 0.01% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.01% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.01% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.01% |
| ESGV | Vanguard ESG U.S. Stock ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| SPGM | State Street SPDR Portfolio MSCI Global Stock Market ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| AVUS | Avantis U.S. Equity ETF | 0.00% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.00% |
| VT | Vanguard Total World Stock ETF | 0.00% |
| AVSU | Avantis Responsible U.S. Equity ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| V3AL.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
PreviousPage 2 of 2
About TXG ETF Exposure
10x Genomics, Inc. (TXG) is held by 91 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.4B, TXG is a widely held institutional stock. The stock currently trades at $19.00. Investors can gain exposure to TXG through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TXG, sorted by portfolio weight.